EPISODE · Apr 4, 2025 · 1H 7M
EASL DeepDive: Evolving insights in role and management of Alpha-1 Antitrypsin Deficiency
from EASL Podcasts · host European Association for the Study of the Liver
In this EASL DeepDive held on 06 November 2024, Alice Turner, Pavel Strnad, and Nicola Brunetti discuss and explore the changing insights in the management of Alpha-1 Antitrypsin Deficiency.Learning objectives:Learn more about the role of heterozygosity of alpha-1 as a risk factor for chronic liver disease, especially in the context of other causes such as MASLD or alcoholGet a better understanding of the extrahepatic manifestations and the need for a multi-disciplinary approachLearn more about screening: who to screen and howDiscover the general unmet needs related to AAT, with an emphasis on awareness and timely diagnosisThis EASL DeepDive webinar is supported by Takeda Pharmaceuticals. Takeda Pharmaceuticals has had no input into the content of this EASL DeepDive.Click here to see all EASL Video Podcasts on Apple Podcasts.
Embed this episode
What this episode covers
In this EASL DeepDive held on 06 November 2024, Alice Turner, Pavel Strnad, and Nicola Brunetti discuss and explore the changing insights in the management of Alpha-1 Antitrypsin Deficiency. Learning objectives: Learn more about the role of heterozygosity of alpha-1 as a risk factor for chronic liver disease, especially in the context of other causes such as MASLD or alcoholGet a better understanding of the extrahepatic manifestations and the need for a multi-disciplinary approachLearn more a...
NOW PLAYING
EASL DeepDive: Evolving insights in role and management of Alpha-1 Antitrypsin Deficiency
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.